Unveiling MicroRNA-21 as a non-invasive diagnostic biomarker in chronic obstructive pulmonary disease-associated pulmonary hypertension: Comparative insights with NT-proBNP | Synapse
Unveiling MicroRNA-21 as a non-invasive diagnostic biomarker in chronic obstructive pulmonary disease-associated pulmonary hypertension: Comparative insights with NT-proBNP
Key Points
To assess the effectiveness of miR-21 as a diagnostic biomarker for pulmonary hypertension in COPD patients.
Comparative analysis of miR-21 and NT-proBNP levels in COPD patients.
Evaluation of miR-21's diagnostic accuracy for pulmonary hypertension.
miR-21 showed greater reliability as a biomarker compared to NT-proBNP.
MicroRNA-21 was identified as a potential non-invasive diagnostic tool for pulmonary hypertension.
Abstract
miR-21 may serve as a useful and reliable biomarker for diagnosing PH in COPD patients, outperforming the traditional biomarker NT-proBNP.